A study on glioma nanomechanics revealed that IDH1 wild-type cells exhibit greater softness compared to IDH1 mutant cells, suggesting that mutants may influence tumor stiffness through the regulation of actin folding and binding, thereby mediating cytoskeletal reorganization, promoting cell sclerosis, and facilitating changes in cell morphology [44]. This evidence concerns the gene IDH1 and central nervous system cancer.